RxDoctor Payments Data

Jordan Gruskay, MD

Sports Medicine · Branford, CTNPI 1922494343

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (42.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 55.0% of the total. Reporting peaked in 2021 at $34,970 and has fallen 99.6% since, to $144 in 2025.

$47,078in general payments, 2019–2025

Across 120 payments — averaging $392.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$26K
  • Smith+Nephew$15K
  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Exactech, Inc.$1K
  • Gemini Mountain Medical, LLC$1K
  • Polaris Technology Solutions LLC$362
  • plus $2K from 11 others

What the payments were for

  • Grants$20,00042%
  • Travel & lodging$4,0789%
  • Food & beverage$3,9128%
  • Education$19,08841%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,078 in reported general payments places this provider in the 85th percentile of 65 sports medicine providers in Connecticut.

See all sports medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$78,866
Medicare patients
117
Services billed
1,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl45$316
Ondansetron Hcl21$264
Methylprednisolone32$229
Meloxicam43$123
Methocarbamol21$82
Tramadol Hcl23$65

Paid to pharmacies, not to this prescriber.

Other sports medicine in Branford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →